Health app "Cara Care for irritable bowel syndrome" obtained reimbursement in Germany

On December 26, 2021, the new health app was introduced in the Directory of digital health applications (DiGAs) at the Federal Office for Drugs and Medical Devices (BfArM) and thus became reimbursable. These apps can be prescribed by physicians and psychotherapists and will be reimbursed by health insurers. In total, 28 health apps are now available at the DiGA Directory.

"Cara Care for irritable bowel syndrome" (HiDoc Technologies GmbH, Germany) is a digital health application used as a stand-alone therapy for irritable bowel syndrome. The health app serves primarily to reduce symptoms of functional gastrointestinal complaints. Secondly, it is expected that the use of the app would help increase the disease-related quality of life, improve health literacy, alleviate anxiety and depression, and activity restrictions. "Cara Care for irritable bowel syndrome" is available in German with a tariff of €718.20.

The full details in German can be found here.

This news is just one of about 300 market access news collected by our team in the subscription services "HTA Alerts" and "Reimbursement Alerts" every two weeks from more than 80 organizations. Access our paid subscription services to stay on top of all developments specifically for your products in Europe (reimbursement news) and globally (HTA news).

Not ready for a subscription service? Subscribe to our free-of-charge newsletter delivered every second week to get updates about key reimbursement developments in Europe (10-12 news every two weeks). First EU issues of both newsletters are available for download free-of-charge.